Propafenone versus vernakalant for conversion of recent-onset atrial fibrillation.
about
Vernakalant is superior to ibutilide for achieving sinus rhythm in patients with recent-onset atrial fibrillation: a randomized controlled trial at the emergency department.Conversion of Recent-Onset Atrial Fibrillation: Which Drug is the Best?Vernakalant hydrochloride to treat atrial fibrillation.Vernakalant for the conversion of atrial fibrillation: the new kid on the block?Intravenous vernakalant for the rapid conversion of recent onset atrial fibrillation: systematic review and meta-analysis.Predictors of conversion of recent-onset atrial fibrillation treated with vernakalant.
P2860
Propafenone versus vernakalant for conversion of recent-onset atrial fibrillation.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Propafenone versus vernakalant for conversion of recent-onset atrial fibrillation.
@en
Propafenone versus vernakalant for conversion of recent-onset atrial fibrillation.
@nl
type
label
Propafenone versus vernakalant for conversion of recent-onset atrial fibrillation.
@en
Propafenone versus vernakalant for conversion of recent-onset atrial fibrillation.
@nl
prefLabel
Propafenone versus vernakalant for conversion of recent-onset atrial fibrillation.
@en
Propafenone versus vernakalant for conversion of recent-onset atrial fibrillation.
@nl
P2093
P2860
P356
P1476
Propafenone versus vernakalant for conversion of recent-onset atrial fibrillation.
@en
P2093
Alberto Giniger
Andrea Corrales Barbosa
Andrés Klein
Diego Conde
Florencia Lambardi
Juan Pablo Costabel
Marcelo Trivi
Martin Aragon
P2860
P304
P356
10.1111/1755-5922.12036
P577
2013-12-01T00:00:00Z